Skip to main content

Peer Review reports

From: Targeting of CD34+CD38-cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

Original Submission
24 Apr 2012 Submitted Original manuscript
15 Jun 2012 Reviewed Reviewer Report - Judith Karp
30 Jun 2012 Reviewed Reviewer Report - Jörg Cammenga
25 Jul 2012 Author responded Author comments - claire SEEDHOUSE
Resubmission - Version 2
25 Jul 2012 Submitted Manuscript version 2
9 Sep 2012 Reviewed Reviewer Report - Judith Karp
19 Sep 2012 Reviewed Reviewer Report - Jörg Cammenga
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
21 Sep 2012 Editorially accepted
26 Sep 2012 Article published 10.1186/1471-2407-12-431

You can find further information about peer review here.

Back to article page